The Streptococcus pneumoniae polysaccharide capsule plays a role in disease severity. We assessed the association of serotype with case-fatality ratio (CFR) in invasive pneumococcal disease (IPD) and meningitis in South Africa, 2012-2018 (vaccine era), using multivariable logistic regression by manual backward elimination. The most common serotypes causing IPD were 8 and 19A. In patients 15 years of age, serotype 15B/C was associated with increased CFR. Among meningitis patients of all ages, serotype 1 was associated with increased CFR. PCV13 serotypes 1, 3, 6A, 19A, and 19F should be monitored, and serotypes 8, 12F, 15A, and 15B/C should be considered for inclusion in vaccines to reduce deaths caused by S. pneumoniae
Serotype 1 is an important cause of invasive pneumococcal disease in South Africa and has declined f...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
INTRODUCTION : South Africa introduced seven-valent pneumococcal conjugate vaccine (PCV7) in 2009 an...
An association between pneumococcal serotypes and mortality has been suggested. We aimed to investig...
An association between pneumococcal serotypes and mortality has been suggested. We aimed to investig...
In South Africa, 7-valent pneumococcal conjugate vaccine (PCV) was introduced in April 2009 and repl...
<div><p>We determined the sequence types of isolates that caused invasive pneumococcal disease (IPD)...
Streptococcus pneumoniae causes life-threatening meningitis. Its capsular polysaccharide determines ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Streptococcus pneumoniae is a major cause of disease, ranging from uncomplicated respiratory infecti...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
BACKGROUND: Bacterial meningitis is a major cause of morbidity and mortality in sub-Saharan Africa. ...
Background. The Streptococcus pneumoniae polysaccharide capsule may be related to invasive pneumococ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
Serotype 1 is an important cause of invasive pneumococcal disease in South Africa and has declined f...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
INTRODUCTION : South Africa introduced seven-valent pneumococcal conjugate vaccine (PCV7) in 2009 an...
An association between pneumococcal serotypes and mortality has been suggested. We aimed to investig...
An association between pneumococcal serotypes and mortality has been suggested. We aimed to investig...
In South Africa, 7-valent pneumococcal conjugate vaccine (PCV) was introduced in April 2009 and repl...
<div><p>We determined the sequence types of isolates that caused invasive pneumococcal disease (IPD)...
Streptococcus pneumoniae causes life-threatening meningitis. Its capsular polysaccharide determines ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Streptococcus pneumoniae is a major cause of disease, ranging from uncomplicated respiratory infecti...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
BACKGROUND: Bacterial meningitis is a major cause of morbidity and mortality in sub-Saharan Africa. ...
Background. The Streptococcus pneumoniae polysaccharide capsule may be related to invasive pneumococ...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
Serotype 1 is an important cause of invasive pneumococcal disease in South Africa and has declined f...
Differences in pathogenicity between pneumococcal serotypes are important when assessing the potenti...
INTRODUCTION : South Africa introduced seven-valent pneumococcal conjugate vaccine (PCV7) in 2009 an...